Antisense modulation of survivin expression

Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Method of regulating cell metabolism or physiology

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S006120, C435S377000, C536S024500, C514S04400A

Reexamination Certificate

active

06838283

ABSTRACT:
Antisense compounds, compositions and methods are provided for modulating the expression of Survivin. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Survivin. Methods of using these compounds for modulation of Survivin expression and for treatment of diseases associated with expression of Survivin are provided.

REFERENCES:
patent: 5801154 (1998-09-01), Baracchini et al.
patent: 6165788 (2000-12-01), Bennett et al.
patent: WO 9822589 (1998-05-01), None
Andrea D. Branch, TIBS 23—Feb. 1998, pp. 45-50.*
Kuang-Yu Jen et al., Stem Cells 2000; pp. 307-319.*
Adida et al., “Anti-apoptosis gene, survivin, and prognosis of neuroblastoma”,Lancet1998 351-882-883.
Ambrosini et al., “A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma”,Nat. Med. 1997 3:917-921.
Ambrosini et al., “Induction of Apoptosis and Inhibition of Cell Proliferation by Survivin Gene Targeting”,J. Bio. Chem. 1998 273:11177-11182.
Cohen G.M., “Caspases:the executioners of apoptosis”,Biochemistry Journal1997 326:1-16.
Li F., et al., “Control of apoptosis and mitotic spindle checkpoint by survivin”,Nature1998 386: 580-584.
Lu et al., “Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas”,Cancer Res., 1998 58:1808-1812.
Genbank Accession No. AW247335, Dec. 16, 1999.
Grossman et al., “Expression of the Apoptosis Inhibitor, Survivin, in Nonmelanoma Skin Cancer and Gene Targeting in a Keratinocyte Cell Line,” Laboratory Investigation, United States and Canadian Academy og Pathology, 29:1121-1126 (1999).
Li et al., “Pleiotropic Cell-Division Defects and Apoptosis Induced by Interference with Survivin Function,” Nature Cell Biology, 1:461-466 (1999).
European Supplementary Search Report. European Application No. EP 01 90 8740.
Altieri, D., “Xa Receptor ERP-1,”FASEB, 9:860-865 (1995).
Altieri, D., “Splicing of Effector Cell Protease Receptor-1 mRNA is Modulated by an Unusual Retained Intron,”Biochemistry, 33:13848-13855 (1994).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Antisense modulation of survivin expression does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antisense modulation of survivin expression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense modulation of survivin expression will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3434005

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.